{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:12:30Z","timestamp":1790230350596,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100013360","name":"Invest NI","doi-asserted-by":"crossref","award":["POC 611"],"award-info":[{"award-number":["POC 611"]}],"id":[{"id":"10.13039\/100013360","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jconrel.2018.04.018","type":"journal-article","created":{"date-parts":[[2018,4,10]],"date-time":"2018-04-10T22:04:15Z","timestamp":1523397855000},"page":"8-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"special_numbering":"C","title":["Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer"],"prefix":"10.1016","volume":"279","author":[{"given":"Heather","family":"Nesbitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingjie","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sukanta","family":"Kamila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiran","family":"Logan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridgeen","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Love","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan","family":"O'Rourke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Beguin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Stride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P.","family":"McHale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"Callan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2018.04.018_bb0005","author":"Transparency Market Research"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0010","doi-asserted-by":"crossref","first-page":"3975","DOI":"10.3892\/ol.2017.6008","article-title":"Neoadjuvant chemotherapy for pancreatic cancer: effects on cancer tissue and novel perspectives","volume":"13","author":"Tajima","year":"2017","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cmrp.2014.03.002","article-title":"Neoadjuvant therapy in pancreatic cancer","volume":"4","author":"Mitra","year":"2014","journal-title":"Curr. Med. Res. Pract."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0020","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0140-6736(15)00986-1","article-title":"Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial","volume":"387","author":"Wang-Gillam","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12957-016-0813-9","article-title":"Gemcitabine plus cisplatin versus gemcitabine alone in the treatment of pancreatic cancer: a meta-analysis","volume":"14","author":"Ouyang","year":"2016","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0030","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.biomaterials.2012.11.048","article-title":"Antiangiogenic-targeting drug-loaded microbubbles combined with focused ultrasound for glioma treatment","volume":"34","author":"Fan","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0035","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.ultrasmedbio.2012.07.013","article-title":"Estimating the delivery efficiency of drug-loaded microbubbles in cancer cells with ultrasound and bioluminescence imaging","volume":"38","author":"Liao","year":"2012","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0040","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.7150\/thno.15164","article-title":"Ultrasound-mediated microbubble destruction (UMMD) facilitates the delivery of CA19-9 targeted and paclitaxel loaded mPEG-PLGA-PLL nanoparticles in pancreatic cancer","volume":"6","author":"Xing","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0045","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/jnci\/djt305","article-title":"Enhanced tumor uptake and penetration of Virotherapy using polymer stealthing and focused ultrasound","volume":"105","author":"Carlisle","year":"2013","journal-title":"JNCI"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0050","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jconrel.2016.10.007","article-title":"A human clinical trial using ultrasound and microbubbles to enhance gemcitabine treatment of inoperable pancreatic cancer","volume":"243","author":"Dimcevski","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jconrel.2015.02.004","article-title":"Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours","volume":"203","author":"McEwan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0060","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.biomaterials.2015.11.033","article-title":"Combined sonodynamic and antimetabolite therapy for the improved treatment of pancreatic cancer using oxygen loaded microbubbles as a delivery vehicle","volume":"80","author":"McEwan","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0065","doi-asserted-by":"crossref","first-page":"325","DOI":"10.20892\/j.issn.2095-3941.2016.0068","article-title":"Recent advances of sonodynamic therapy in cancer treatment","volume":"13","author":"Wan","year":"2016","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0070","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ccr.2005.04.023","article-title":"Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice","volume":"7","author":"Hingorani","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0075","unstructured":"Invitrogen TRIzol Reagent Guide. https:\/\/tools.thermofisher.com\/content\/sfs\/manuals\/trizol_reagent.pdf, 2016 (accessed 11 November 2017)."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0080","unstructured":"Roche, Transcriptor first strand cDNA synthesis kit.http:\/\/facstaff.bloomu.edu\/gdavis\/MoBio\/Transcriptor%20full%20manual.pdf, 2006 (accessed 11 Noveember 2017)."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0085","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0090","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0095","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.2174\/138161212800626175","article-title":"Molecular targets of gemcitabine action: rationale for development of novel drugs and drug combinations","volume":"18","author":"Elnaggar","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0100","first-page":"283","article-title":"Theranostic reduction-sensitive gemcitabine prodrug micelles for near-infrared imaging and pancreatic cancer therapy","volume":"8","author":"Han","year":"2016","journal-title":"Nano"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40170-014-0026-z","article-title":"Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302","volume":"3","author":"Wojtkowiak","year":"2015","journal-title":"Cancer Metab."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0110","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/bjc.2016.29","article-title":"Androgen deprivation in LNCaP prostate tumour xenografts induces vascular changes and hypoxic stress, resulting in promotion of epithelial-to-mesenchymal transition","volume":"114","author":"Byrne","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0115","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1136\/jcp.2003.015032","article-title":"The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis","volume":"57","author":"Greijer","year":"2004","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0120","series-title":"Anonymous Diverse Effects of Hypoxia on Tumor Progression","first-page":"21","article-title":"Hypoxia and hypoxia inducible factors in cancer stem cell maintenance","author":"Li","year":"2010"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0125","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1423-0127-19-102","article-title":"Hypoxia-regulated target genes implicated in tumor metastasis","volume":"19","author":"Tsai","year":"2012","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0130","doi-asserted-by":"crossref","first-page":"23482","DOI":"10.1074\/jbc.M601719200","article-title":"Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system","volume":"281","author":"Stiehl","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0135","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/20459","article-title":"The tumor suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis","volume":"399","author":"ER","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0140","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S1535-6108(02)00043-0","article-title":"Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein","volume":"1","author":"Kondo","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0145","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S0092-8674(00)80259-7","article-title":"Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development","volume":"89","author":"Otto","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0150","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1128\/MCB.25.19.8581-8591.2005","article-title":"The Runx2 osteogenic transcription factor regulates matrix metalloproteinase 9 in bone metastatic cancer cells and controls cell invasion","volume":"25","author":"Pratap","year":"2005","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0155","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1038\/bjc.2012.455","article-title":"Bicalutamide-induced hypoxia potentiates RUNX2-mediated Bcl-2 expression resulting in apoptosis resistance","volume":"107","author":"Browne","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jcp.25093","article-title":"Nitric oxide up-regulates RUNX2 in LNCaP prostate tumours: implications for tumour growth in vitro and in vivo","volume":"231","author":"Nesbitt","year":"2016","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0165","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0925-4773(01)00428-2","article-title":"Tissue specific regulation of VEGF expression during bone development requires Cbfa1\/Runx2","volume":"106","author":"Zelzer","year":"2001","journal-title":"Mech. Dev."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0170","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.4049\/jimmunol.170.6.3369","article-title":"IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis","volume":"170","author":"Li","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0175","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1111\/cas.12198","article-title":"Histological and prognostic importance of CD44\/CD24\/EpCAM expression in clinical pancreatic cancer","volume":"104","author":"Ohara","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0180","doi-asserted-by":"crossref","first-page":"649IN7","DOI":"10.1593\/tlo.13556","article-title":"Antidiabetic drug metformin prevents progression of pancreatic cancer by targeting in part cancer stem cells and mTOR signaling","volume":"6","author":"Mohammed","year":"2013","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0185","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1158\/0008-5472.CAN-10-2738","article-title":"DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism","volume":"71","author":"Sureban","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0190","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.4161\/cc.8.7.8041","article-title":"Genomic instability en route to and from cancer stem cells","volume":"8","author":"Li","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0195","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.canlet.2016.08.023","article-title":"Gemcitabine treatment promotes pancreatic cancer stemness through the Nox\/ROS\/NF\/STAT3 signaling cascade","volume":"382","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0200","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2018.04.018_bb0205","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0210","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MPA.0b013e3181c15963","article-title":"Phenotype and genotype of pancreatic cancer cell lines","volume":"39","author":"Deer","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0215","doi-asserted-by":"crossref","first-page":"5055","DOI":"10.1038\/onc.2014.425","article-title":"SMAD4 exerts a tumor-promoting role in hepatocellular carcinoma","volume":"34","author":"Hernanda","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0220","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1002\/hep.22109","article-title":"Serum activity of alanine aminotransferase (ALT) as an indicator of health and disease","volume":"47","author":"Kim","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.jconrel.2018.04.018_bb0225","author":"Cancer Treatment Centers of America"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365918302025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T08:19:26Z","timestamp":1563610766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365918302025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":45,"alternative-id":["S0168365918302025"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.04.018","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gemcitabine loaded microbubbles for targeted chemo-sonodynamic therapy of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2018.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}